Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,388.60 +34.18 0.22%
S&P 500 1,671.91 +4.44 0.27%
Nasdaq 3,508.16 +9.19 0.26%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

72.8300 USD 0.1800 0.25%

As of 11:53:31 ET on 05/20/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 73.0100 High - Low: 73.3800 - 72.6500 Primary Exchange: NYSE Arca
Volume: 79,135 52-Week Range: 43.6362 - 75.4400 Beta vs MVBBHTR: -

ETF Chart for BBH

No chart data available.
  • BBH:US 72.8300
  • 1D
  • 1M
  • 1Y
73.0100
Interactive BBH Chart

Previous Close

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: HAO-HUNG LIAO "PETER"
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2013-05-17) 72.9714
Assets (M) (on 2013-04-30) 299.9324
Shares out (M) 4.50
Market Cap (M) 327.73
% Premium 0.05
Average 52-Week % Premium 0.0381
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2012-12-24) 0.0180
Dividend Yield (ttm) 0.25%

Performance for BBH

1-Month +7.18% 1-Year +60.55%
3-Month +25.88% 3-Year -
Year To Date +36.47% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 05/17/2013
Name Position Value % of Total
Gilead Sciences Inc 838,276 47,194,939 14.389%
Amgen Inc 416,268 43,970,389 13.406%
Biogen Idec Inc 131,428 29,814,442 9.090%
Celgene Corp 232,900 29,091,539 8.869%
Vertex Pharmaceuticals Inc 252,828 20,097,298 6.127%
Regeneron Pharmaceuticals Inc 71,707 19,143,618 5.837%
Alexion Pharmaceuticals Inc 149,322 15,365,234 4.685%
Life Technologies Corp 208,762 15,352,357 4.681%
Illumina Inc 211,892 15,256,224 4.651%
BioMarin Pharmaceutical Inc 204,363 13,081,276 3.988%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil